207 related articles for article (PubMed ID: 17961316)
1. In vitro expression of beta-thalassaemia gene (IVS1-1G>C) reveals complete inactivation of the normal 5' splice site and alternative aberrant RNA splicing.
Fujihara N; Yamauchi K; Hirota-Kawadobora M; Ishikawa S; Tozuka M; Ishii E; Katsuyama T; Okumura N; Taniguchi S
Ann Clin Biochem; 2007 Nov; 44(Pt 6):573-8. PubMed ID: 17961316
[TBL] [Abstract][Full Text] [Related]
2. Reversal of aberrant splicing of beta-thalassemia allele by antisense RNA in vitro and in vivo.
Zeng Y; Gu X; Chen Y; Gong L; Ren Z; Huang S
Chin Med J (Engl); 1999 Feb; 112(2):107-11. PubMed ID: 11593572
[TBL] [Abstract][Full Text] [Related]
3. Defective RNA splicing resulting from a mutation in the cyclic guanosine monophosphate-phosphodiesterase beta-subunit gene.
Piriev NI; Shih JM; Farber DB
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):463-70. PubMed ID: 9501854
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism of beta-thalassaemia caused by 22-bp duplication.
Svasti S; Boonchoy C; Vanichsetakul P; Winichagoon P; Fucharoen S
Ann Hematol; 2008 Aug; 87(8):633-7. PubMed ID: 18392622
[TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of the α-thalassemia point mutation HBA2:c.95+1G>A [IVS-I-1(G>A) (α2)].
Qadah T; Finlayson J; Ghassemifar R
Hemoglobin; 2012; 36(1):38-46. PubMed ID: 21967524
[TBL] [Abstract][Full Text] [Related]
6. Novel beta-thalassemia trait (IVS I-1 G-->C) in a Japanese family.
Fujihara N; Tozuka M; Ueno I; Yamauchi K; Nakagoshi R; Ishikawa S; Hirota M; Okumura N; Ishii E; Katsuyama T
Am J Hematol; 2003 Jan; 72(1):64-6. PubMed ID: 12508270
[TBL] [Abstract][Full Text] [Related]
7. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
[TBL] [Abstract][Full Text] [Related]
8. "Silent" nucleotide substitution in codon 24 of a beta+ thalassemia globin gene activates splice site in coding sequence RNA.
Humphries RK; Ley T; Goldsmith ME; Kantor JA; Cline AC; Nienhuis AW
Prog Clin Biol Res; 1983; 134():123-6. PubMed ID: 6664994
[TBL] [Abstract][Full Text] [Related]
9. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
[TBL] [Abstract][Full Text] [Related]
10. A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro.
Thi Tran HT; Takeshima Y; Surono A; Yagi M; Wada H; Matsuo M
Mol Genet Metab; 2005 Jul; 85(3):213-9. PubMed ID: 15979033
[TBL] [Abstract][Full Text] [Related]
11. Correction of aberrant pre-mRNA splicing by antisense oligonucleotides in beta-thalassemia Egyptian patients with IVSI-110 mutation.
El-Beshlawy A; Mostafa A; Youssry I; Gabr H; Mansour IM; El-Tablawy M; Aziz M; Hussein IR
J Pediatr Hematol Oncol; 2008 Apr; 30(4):281-4. PubMed ID: 18391696
[TBL] [Abstract][Full Text] [Related]
12. A novel frameshift mutation (+G) at codons 15/16 in a beta0 thalassaemia gene results in a significant reduction of beta globin mRNA values.
Mo QH; Li XR; Li CF; He YL; Xu XM
J Clin Pathol; 2005 Sep; 58(9):923-6. PubMed ID: 16126871
[TBL] [Abstract][Full Text] [Related]
13. Two aberrant splicings caused by mutations in the insulin receptor gene in cultured lymphocytes from a patient with Rabson-Mendenhall's syndrome.
Takahashi Y; Kadowaki H; Ando A; Quin JD; MacCuish AC; Yazaki Y; Akanuma Y; Kadowaki T
J Clin Invest; 1998 Feb; 101(3):588-94. PubMed ID: 9449692
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of three novel splicing mutations causing factor V deficiency and analysis of the F5 gene splicing pattern.
Dall'Osso C; Guella I; Duga S; Locatelli N; Paraboschi EM; Spreafico M; Afrasiabi A; Pechlaner C; Peyvandi F; Tenchini ML; Asselta R
Haematologica; 2008 Oct; 93(10):1505-13. PubMed ID: 18728029
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of globin gene expression in different thalassaemia disorders: individual variation of β(E) pre-mRNA splicing determine disease severity.
Tubsuwan A; Munkongdee T; Jearawiriyapaisarn N; Boonchoy C; Winichagoon P; Fucharoen S; Svasti S
Br J Haematol; 2011 Sep; 154(5):635-43. PubMed ID: 21732929
[TBL] [Abstract][Full Text] [Related]
16. [Repair of the splicing defect of thalassemic allele beta IVS-2-654 C-->T in cultured human erythroid cells by antisense RNA].
Gu X; Gong L; Zhang W
Zhonghua Yi Xue Za Zhi; 1997 Nov; 77(11):815-8. PubMed ID: 9772473
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing of the rabbit beta-globin pre-mRNA in vivo after transient transfection of myoblast and myotube cells.
Pironcheva GL; Russev G
Microbios; 1997; 89(358):31-8. PubMed ID: 9218353
[TBL] [Abstract][Full Text] [Related]
18. Cryptic splicing sites are differentially utilized in vivo.
Haj Khelil A; Deguillien M; Morinière M; Ben Chibani J; Baklouti F
FEBS J; 2008 Mar; 275(6):1150-62. PubMed ID: 18266765
[TBL] [Abstract][Full Text] [Related]
19. Determination of neutral polymorphisms (frameworks) of the human beta globin gene in beta thalassaemias by PCR/DGGE.
Moreira HW; de Oliveira CM; Martins CS; de Sales TS; Costa FF
Sangre (Barc); 1997 Feb; 42(1):21-4. PubMed ID: 9097718
[TBL] [Abstract][Full Text] [Related]
20. Cellular expression and siRNA-mediated interference of rhodopsin cis-acting splicing mutants associated with autosomal dominant retinitis pigmentosa.
Hernan I; Gamundi MJ; Planas E; Borràs E; Maseras M; Carballo M
Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3723-9. PubMed ID: 21357407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
